HAG:XETRHENSOLDT AG Analysis
Data as of 2026-08-23 - not real-time
€89.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At €89.30, Hensoldt AG shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 20.2% over the past 30 days. Relative strength is 55.2 — neutral — and the MACD signal is bearish. The recent range runs from support at €77.64 up to resistance at €96.70.
Valuation screens as overvalued: a P/E of 85.9 sits above the sector average of 29.9. Sell-side targets cluster 3.7% above the current quote. Revenue is growing at 22.2% on a 4.5% profit margin. The 0.62% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 39.5%, a beta of 0.09 and a maximum drawdown of 43.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Valuation screens as overvalued: a P/E of 85.9 sits above the sector average of 29.9. Sell-side targets cluster 3.7% above the current quote. Revenue is growing at 22.2% on a 4.5% profit margin. The 0.62% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 39.5%, a beta of 0.09 and a maximum drawdown of 43.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 79.28
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 85.9 versus sector average of 29.9
- Trading above the 200-day average of 79.28
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 85.9 versus sector average of 29.9
- Revenue growth of +22.2%
- Dividend yield of 0.62%
Key Metrics & Analysis
Financial Health
Revenue Growth22.20%
Profit Margin4.48%
P/E Ratio85.9
ROE12.93%
ROA3.06%
Debt/Equity172.80
P/B Ratio11.6
Op. Cash Flow€567.0M
Free Cash Flow€304.0M
Industry P/E29.9
Technical Analysis
TrendBullish
RSI55.2
Support€77.64
Resistance€96.70
MA 20€89.12
MA 50€79.69
MA 200€79.28
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value€73.29
Target Price€92.63
Upside/Downside3.73%
GradeOvervalued
TypeGrowth
Dividend Yield0.62%
Risk Assessment
Beta0.09
Volatility39.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.